138 related articles for article (PubMed ID: 35872330)
1. Effects of obesity on neuroinflammatory and neurochemical parameters in an animal model of reserpine-induced Parkinson's disease.
Cavalheiro EKFF; da Silva LE; Oliveira MP; Silva MG; Damiani AP; Ribeiro CB; Magenis ML; Cucker L; Michels M; Joaquim L; Machado RS; Vilela TC; Bitencourt RM; Andrade VM; Dal-Pizzol F; Petronilho F; Tuon T; Rezin GT
Behav Brain Res; 2022 Sep; 434():114019. PubMed ID: 35872330
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson's disease induced by reserpine.
Tharwat EK; Abdelaty AO; Abdelrahman AI; Elsaeed H; Elgohary A; El-Feky AS; Ebrahim YM; Sakraan A; Ismail HA; Khadrawy YA; Aboul Ezz HS; Noor NA; Fahmy HM; Mohammed HS; Mohammed FF; Radwan NM; Ahmed NA
Metab Brain Dis; 2023 Jun; 38(5):1513-1529. PubMed ID: 36847968
[TBL] [Abstract][Full Text] [Related]
3. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease.
Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS
Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943
[TBL] [Abstract][Full Text] [Related]
4. Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease.
Bispo JMM; Melo JEC; Gois AM; Medeiros KAAL; Silva RS; Leal PC; Franco HS; Souza MF; Lins LCRF; Ribeiro AM; Silva RH; Santos JR
Brain Res Bull; 2022 Sep; 187():162-168. PubMed ID: 35781030
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.
Cai LJ; Tu L; Li T; Yang XL; Ren YP; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian JY
Aging (Albany NY); 2020 Jan; 12(1):672-689. PubMed ID: 31927536
[TBL] [Abstract][Full Text] [Related]
6. Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.
Rahman MM; Chakraborti RR; Potol MA; Abir AH; Sharmin O; Alam M; Khan MFR; Afrin R; Jannat H; Wadud R; Habib ZF
Animal Model Exp Med; 2020 Mar; 3(1):9-21. PubMed ID: 32318655
[TBL] [Abstract][Full Text] [Related]
7. Effects of gold nanoparticles administration through behavioral and oxidative parameters in animal model of Parkinson's disease.
da Silva Córneo E; de Bem Silveira G; Scussel R; Correa MEAB; da Silva Abel J; Luiz GP; Feuser PE; Silveira PCL; Machado-de-Ávila RA
Colloids Surf B Biointerfaces; 2020 Dec; 196():111302. PubMed ID: 32777662
[TBL] [Abstract][Full Text] [Related]
8. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.
Kanthasamy A; Jin H; Mehrotra S; Mishra R; Kanthasamy A; Rana A
Neurotoxicology; 2010 Sep; 31(5):555-61. PubMed ID: 20005250
[TBL] [Abstract][Full Text] [Related]
9. α-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson's disease.
Javed H; Meeran MFN; Azimullah S; Bader Eddin L; Dwivedi VD; Jha NK; Ojha S
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33049992
[TBL] [Abstract][Full Text] [Related]
10. High concentrations of fructose cause brain damage in mice.
Cargnin-Carvalho A; da Silva MR; Costa AB; Engel NA; Farias BX; Bressan JB; Backes KM; de Souza F; da Rosa N; de Oliveira Junior AN; Goldim MPS; Correa MEAB; Venturini LM; Fortunato JJ; Prophiro JS; Petronilho F; Silveira PCL; Ferreira GK; Rezin GT
Biochem Cell Biol; 2023 Aug; 101(4):313-325. PubMed ID: 36947832
[TBL] [Abstract][Full Text] [Related]
11. High fat diet-induced obesity causes a reduction in brain tyrosine hydroxylase levels and non-motor features in rats through metabolic dysfunction, neuroinflammation and oxidative stress.
Bittencourt A; Brum PO; Ribeiro CT; Gasparotto J; Bortolin RC; de Vargas AR; Heimfarth L; de Almeida RF; Moreira JCF; de Oliveira J; Gelain DP
Nutr Neurosci; 2022 May; 25(5):1026-1040. PubMed ID: 33078695
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson's disease.
El-Ghazaly MA; Sadik NA; Rashed ER; Abd-El-Fattah AA
Toxicol Ind Health; 2015 Dec; 31(12):1128-43. PubMed ID: 23696346
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ethanolic Extract of Cynara cardunculus (Artichoke) Leaves on Neuroinflammatory and Neurochemical Parameters in a Diet-Induced Mice Obesity Model.
Piccinini A; Oliveira MP; Silva MR; Bett GS; Becker IB; Mendes TF; Salla DH; Silva LE; Vilela TC; Moraes FM; Moterle D; Damiani AP; Dagostin LS; Tietbohl LT; Bittencourt JVS; Biehl E; Denicol TL; Bonfante SR; Andrade VM; Silveira PCL; Prophiro JS; Ferreira GK; Petronilho F; Kanis LA; Rezin GT
Neurochem Res; 2022 Jul; 47(7):1888-1903. PubMed ID: 35426598
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Mani S; Sevanan M; Krishnamoorthy A; Sekar S
Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
[TBL] [Abstract][Full Text] [Related]
16. A Novel Synthetic Precursor of Styryl Sulfone Neuroprotective Agents Inhibits Neuroinflammatory Responses and Oxidative Stress Damage through the P38 Signaling Pathway in the Cell and Animal Model of Parkinson's Disease.
Guo Y; Ma Z; Ning X; Chen Y; Tian C; Wang X; Zhang Z; Liu J
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500807
[TBL] [Abstract][Full Text] [Related]
17. Behavior and oxidative stress parameters in rats subjected to the animal's models induced by chronic mild stress and 6-hydroxydopamine.
Tuon T; Meirelles SS; de Moura AB; Rosa T; Borba LA; Botelho MEM; Abelaira HM; de Mathia GB; Danielski LG; Fileti ME; Petronilho F; Ignácio ZM; Quevedo J; Réus GZ
Behav Brain Res; 2021 May; 406():113226. PubMed ID: 33684423
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in the medullary respiratory neurons contributes to respiratory dysfunction in the 6-OHDA model of Parkinson's disease.
Falquetto B; Thieme K; Malta MB; E Rocha KC; Tuppy M; Potje SR; Antoniali C; Rodrigues AC; Munhoz CD; Moreira TS; Takakura AC
J Physiol; 2020 Nov; 598(22):5271-5293. PubMed ID: 32820824
[TBL] [Abstract][Full Text] [Related]
19. Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
Langley M; Ghosh A; Charli A; Sarkar S; Ay M; Luo J; Zielonka J; Brenza T; Bennett B; Jin H; Ghaisas S; Schlichtmann B; Kim D; Anantharam V; Kanthasamy A; Narasimhan B; Kalyanaraman B; Kanthasamy AG
Antioxid Redox Signal; 2017 Nov; 27(14):1048-1066. PubMed ID: 28375739
[TBL] [Abstract][Full Text] [Related]
20. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
